The Present and FutureJACC Review Topic of the WeekTargeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Emdin has received consulting fees from Merck; and serves as an Italian national leader investigator of VICTORIA. Dr. Metra has received consulting fees from Bayer, Fresenius, Novartis, and Windtree Therapeutics for participation on Advisory Boards or Executive Committees of clinical trials. Dr. Senni has received consulting fees from Bayer, Merck, Novartis, Vifor Pharma, Abbott, Boehringer Ingelheim, AstraZeneca, BioVentrix, and Servier; and serves as an Italian national leader investigator of VICTORIA. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.
- ∗
Drs. Emdin and Aimo contributed equally to this work.